Articles and posts USelectAllNewsClinical study on 100 newborn babies with Neola Medical’s medical technology device completed, positive subgroup results presentedSeptember 21, 2022 | News, Non regulatoryPresentation at ABG Sundal Collier’s Investor Day 2022September 20, 2022 | News, PresentationsAcquisition of IP rights, clinical study results, owner’s increased shares and the coming rights issue – CEO tells more in Neola Medicals investor letterSeptember 15, 2022 | News, Non regulatoryNeola Medical’s CEO Hanna Sjöström presents at ABG Sundal Colliers Investor Day the 13th of SeptemberSeptember 12, 2022 | News, Non regulatoryNeola Medical AB: Notice of extraordinary general meeting in Neola Medical ABSeptember 8, 2022 | News, Non regulatoryThe board of directors of Neola Medical has resolved on a rights issue of approximately SEK 55 million subject to approval by an Extraordinary General MeetingSeptember 8, 2022 | News, RegulatoryNeola Medical at the UENPS congress 2022September 6, 2022 | NewsDo not miss BioStock’s latest article about Neola Medical with CEO Hanna SjöströmSeptember 1, 2022 | NewsClinical Manager recruited – Neola Medical strengthens the team with a neonatologistSeptember 1, 2022 | News, Non regulatoryCEO Hanna Sjöström at The Future of Swedish & Danish Life Science 7th of SeptemberAugust 25, 2022 | NewsCEO and CFO presents Q2 report for 2022August 17, 2022 | News, PresentationsQ2 report 2022- a quarter with big commercial steps forwardAugust 16, 2022 | Articles, News, Regulatory# 12345678910111213 $ For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
Clinical study on 100 newborn babies with Neola Medical’s medical technology device completed, positive subgroup results presentedSeptember 21, 2022 | News, Non regulatory
Acquisition of IP rights, clinical study results, owner’s increased shares and the coming rights issue – CEO tells more in Neola Medicals investor letterSeptember 15, 2022 | News, Non regulatory
Neola Medical’s CEO Hanna Sjöström presents at ABG Sundal Colliers Investor Day the 13th of SeptemberSeptember 12, 2022 | News, Non regulatory
Neola Medical AB: Notice of extraordinary general meeting in Neola Medical ABSeptember 8, 2022 | News, Non regulatory
The board of directors of Neola Medical has resolved on a rights issue of approximately SEK 55 million subject to approval by an Extraordinary General MeetingSeptember 8, 2022 | News, Regulatory
Do not miss BioStock’s latest article about Neola Medical with CEO Hanna SjöströmSeptember 1, 2022 | News
Clinical Manager recruited – Neola Medical strengthens the team with a neonatologistSeptember 1, 2022 | News, Non regulatory
CEO Hanna Sjöström at The Future of Swedish & Danish Life Science 7th of SeptemberAugust 25, 2022 | News
Q2 report 2022- a quarter with big commercial steps forwardAugust 16, 2022 | Articles, News, Regulatory